SwePub
Sök i LIBRIS databas

  Extended search

id:"swepub:oai:DiVA.org:kth-287132"
 

Search: id:"swepub:oai:DiVA.org:kth-287132" > Cerebrospinal Fluid...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00003922naa a2200613 4500
001oai:DiVA.org:kth-287132
003SwePub
008201207s2020 | |||||||||||000 ||eng|
009oai:prod.swepub.kib.ki.se:144396035
024a https://urn.kb.se/resolve?urn=urn:nbn:se:kth:diva-2871322 URI
024a https://doi.org/10.1002/mds.281922 DOI
024a http://kipublications.ki.se/Default.aspx?queryparsed=id:1443960352 URI
040 a (SwePub)kthd (SwePub)ki
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Markaki, I.u Karolinska Institutet4 aut
2451 0a Cerebrospinal Fluid Levels of Kininogen-1 Indicate Early Cognitive Impairment in Parkinson’s Disease
264 c 2020-08-15
264 1b John Wiley & Sons,c 2020
338 a print2 rdacarrier
500 a QCR 202007
520 a Background: Cognitive impairment is common in patients with PD. Core markers of Alzheimer’s dementia have been related also to PD dementia, but no disease-specific signature to predict PD dementia exists to date. Objectives: The aim of this study was to investigate CSF markers associated with cognition in early PD. Methods: A high-throughput suspension bead array examined 216 proteins in CSF of 74 PD patients in the AETIONOMY project. Cognitive function was assessed with Repeatable Battery for the Assessment of the Neuropsychological Status, Montreal Cognitive Assessment, and Mini-Mental State Examination. Results: Of 69 patients with complete data, 34 had high (≥90) and 35 had low Repeatable Battery for the Assessment of the Neuropsychological Status total score (<90). Of 14 proteins in CSF that differed in levels between groups, increased kininogen-1, validated with several antibodies, was independently associated with lower Repeatable Battery for the Assessment of the Neuropsychological Status and Montreal Cognitive Assessment scores after adjustment for confounders. Conclusions: Kininogen-1 levels in CSF may serve as a marker of cognitive impairment in PD.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Medicinska och farmaceutiska grundvetenskaperx Neurovetenskaper0 (SwePub)301052 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Basic Medicinex Neurosciences0 (SwePub)301052 hsv//eng
653 a cognition
653 a kininogen-1
653 a neurodegeneration
653 a Parkinson’s disease
700a Bergström, Sofiau KTH,Affinitets-proteomik4 aut0 (Swepub:kth)u1ugb8pi
700a Tsitsi, P.u Karolinska Institutet4 aut
700a Remnestål, Juliau KTH,Affinitets-proteomik4 aut0 (Swepub:kth)u13wztpi
700a Månberg, Anna,d 1985-u KTH,Affinitets-proteomik4 aut0 (Swepub:kth)u1g5roxd
700a Hertz, E.4 aut
700a Paslawski, W.u Karolinska Institutet4 aut
700a Sorjonen, K.u Karolinska Institutet4 aut
700a Uhlén, Mathiasu Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden4 aut0 (Swepub:kth)u1dulvmw
700a Mangone, G.4 aut
700a Carvalho, S.4 aut
700a Rascol, O.4 aut
700a Meissner, W. G.4 aut
700a Magnin, E.4 aut
700a Wüllner, U.4 aut
700a Corvol, J. -C4 aut
700a Nilsson, Peteru KTH,Affinitets-proteomik4 aut0 (Swepub:kth)u1ws88sk
700a Svenningsson, P.u Karolinska Institutet4 aut
710a Karolinska Institutetb Affinitets-proteomik4 org
773t Movement Disordersd : John Wiley & Sonsx 0885-3185x 1531-8257
856u https://doi.org/10.1002/mds.28192y Fulltext
856u https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28192
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:kth:diva-287132
8564 8u https://doi.org/10.1002/mds.28192
8564 8u http://kipublications.ki.se/Default.aspx?queryparsed=id:144396035

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view